Invited commentary: Cardiovascular mortality in subclinical hyperthyroidism: An ongoing dilemma

European Journal of Endocrinology

Volumn 162, Issue 3, 2010, Pages 587-589

  Biondi, Bernadette ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; DISEASE ASSOCIATION; FOLLOW UP; GROUPS BY AGE; HEART DISEASE; HUMAN; HYPERTHYROIDISM; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; SUBCLINICAL HYPERTHYROIDISM; THYROID DISEASE; THYROTROPIN BLOOD LEVEL;

CARDIOVASCULAR DISEASES; HUMANS; HYPERTHYROIDISM;

EID: 77149132742     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1095     Document Type: Article

References (18)

1. Biondi B & Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews 2008 29 76-131.
2. Biondi B. Should we treat all subjects with subclinical thyroid disease the same way? European Journal of Endocrinology 2008 159 343-345.
3. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP & Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. Journal of the American Medical Association 2006 295 1033-1041.
4. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ & D'Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New England Journal of Medicine 1994 331 1249-1252.
5. Bauer DC, Rodondi N, Stone KL, Hillier TA & Study of Osteoporotic Fractures Research Group: Universities of California (San Francisco), Pittsburgh, Minnesota (Minneapolis); Kaiser Permanente Center for Health Research, Portland. Thyroid hormone use, hyperthyroidism and mortality in older women. American Journal of Medicine 2007 120 343-349.
6. Flynn RW, Bonellie SR, Jung RT, Macdonald TM, Morris AD & Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. Journal of Clinical Endocrinology and Metabolism 2010 95 186-193.
7. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M & Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. Journal of the American Medical Association 2004 292 2591-2599.
8. van den Beld AW, Visser TJ, Feelders RA, Grobbee DE & Lamberts SW. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. Journal of Clinical Endocrinology and Metabolism 2005 90 6403-6409.
9. Biondi B & Cooper DS. Benefits of TSH suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid, 2010.
10. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001 358 861-865.
11. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P & Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of Internal Medicine 2005 165 2467-2472.
12. Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, L'Abbate A & Pingitore A. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Archives of Internal Medicine 2007 167 1526-1532.
13. Radácsi A, Kovács G, Bernard W, Feldkamp J, Horster FA & Szabolcs I. Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study. Endocrine 2003 21 133-136.
14. Chubb SA, Davis WA & Davis TM. Subclinical hypothyroidism and mortality in women with type 2 diabetes. Clinical Endocrinology 2006 6 476-477.
15. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J & Rodondi N. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Annals of Internal Medicine 2008 148 832-845.
16. Haentjens P, VanMeerhaeghe A, Poppe K & Velkeniers B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies.European Journal of Endocrinology 2008 159 343-345.
17. Ittermann T, Haring R, Sauer S, Wallaschofski H, Dörr M, Nauck M & Volzke H. Decreased serum TSH levels are not associated with mortality in the adult northeast German population. European Journal of Endocrinology 2010 162 579-585.
18. Sgarbi J, Matsumura L, Kasamatsu T, Ferreira S & Maciel R. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5 year follow-up: the Japanese-Brazilian thyroid study. European Journal of Endocrinology 2010 162 569-577.